Impact of FDG PET on the management of TBC treatment: A pilot study

NuklearMedizin

Volumn 49, Issue 1, 2010, Pages 35-40

  Sathekge, M ^a   Maes, A ^b,c   Kgomo, M ^d   Stoltz, A ^a   Pottel, H ^e   Van De Wiele, C ^f  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b AZ Groeninge ^*  (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d Department of Internal Medicine   (South Africa)

^e UNIVERSITY OF LEUVEN   (Belgium)

^f GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

CT; FDG PET; Patient management; Treatment; Tuberculosis

Indexed keywords

CORTICOSTEROID; FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EXTRAPULMONARY TUBERCULOSIS; FEMALE; GOLD STANDARD; HISTOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MILIARY TUBERCULOSIS; POSITRON EMISSION TOMOGRAPHY; PRESCHOOL CHILD; SPUTUM CYTODIAGNOSIS; TREATMENT PLANNING; TUBERCULOUS MENINGITIS; TUBERCULOUS PERICARDITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE DISEASES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INFANT; JOINT DISEASES; LUNG; LYMPH NODES; MALE; MIDDLE AGED; PILOT PROJECTS; PLEURAL EFFUSION; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED; TUBERCULOSIS;

EID: 76749149629     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.3413/nukmed-0270     Document Type: Article

References (27)

1. Adams D. The granulomatous inflammatory response: a review. Am J Pathol 1976; 84: 161-191.
2. Arciniegas W, Orjuela D. Extrapulmonary tuberculosis: a review of 102 cases in Pereira, Colombia. Biomedica 2006; 26: 71-80.
3. Bakheet S, Powe J. Benign causes of 18-FDG uptake on whole-body imaging. Semin Nucl Med 2000; 28: 352-358.
4. Brown R, Leung J, Fisher S et al. Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: are inflammatory cells important? J Nucl Med 1995; 36: 1854-1861.
5. Cameron R. Inflammation and repair. In: Robbins SL (ed). Pathology. Philadelphia, PA: WB Saunders 1967; 31-37.
6. Cazin M, Paluszezal D, Bianchi A et al. Effects of anaerobosis upon morphology and energy metabolism of alveloar macrophages cultured in gas phase. Eur Respir J 1990; 3: 1015-1022.
7. Dannenberg A, Tamashefski J. Pathogenesis of pulmonary tuberculosis. In: Fishman A, Elias J, Fishman J et al. (eds). Fishman's pulmonary disease and disorders. New York, NY: McGraw-Hill 1998; 2447-2471.
8. De Backer A, Mortelé K, De Keulenaer B, Parizel P. Tuberculosis: epidemiology, manifestations and the value of medical imaging in diagnosis. JBR-BTR 2006; 89: 243-250.
9. Demura Y, Tsuchida T, Uesaka D et al. Usefulness of 18F- fluorodeoxyglucose positron emission tomography for diagnosing disease activity and monitoring therapeutic response in patients with pulmonary mycobacteriosis. Eur J Nucl Med Mol Imaging 2009; 36: 632-639.
10. Deol P, Vohra R, Saini A, et al. Role of mycobacterium tuberculosis Ser/Thr kinase PknF: in glucose transport and cell division. J Bacteriol 2005; 187: 3415-3420.
11. 18F-FDG PET imaging in assessing exudative pleural effusions. Nucl Med Commun 2006; 27: 971-976.
12. Golden M, Vikram H. Extrapulmonary tuberculosis: an overview. Am Fam Physician 2005; 72: 1761-1768.
13. Goo J, Im H, Do K et al. Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases. Radiology 2000; 216: 117-121.
14. Grandjean L, Moore D. Tuberculosis in the developing world: recent advances in diagnosis with special consideration of the extensively drug-resistant tuberculosis. Curr Opin Infect Dis 2008; 21: 454-461.
15. 11C-choline in lung cancer and pulmonary tuberculosis. Chest 2003; 124: 893-901.
16. Hellwig D, Baum RP, Kirsch CM. FDG-PET, PET/ CT and conventional nuclear medicine procedures in the evaluation of lung cancer - A systematic review. Nuklearmedizin 2009; 48: 59-69.
17. Jeong Y, Lee K. Pulmonary tuberculosis : up-to-date imaging and management. Am J Roentgenol 2008; 191: 834-844.
18. Kubota R, Yamada S, Kubota K et al. Intratumoral distribution of fluorine-18-deoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33: 1972-1980.
19. 18F-FDG PET-CT for determination of pulmonary tuberculoma activity. Eur J Nucl Med Mol Imaging 2008; 35: 808-814.
20. 18F-FDG PET/CT. Nuklearmedizin 2009; 48: 153-158.
21. 18F fluoro-2-deoxy-D-glucose PET in the detection of osteomyelitis. Radiol Clin North Am 2007; 45: 719-733.
22. Pai M, O'Brien R. New diagnostics for latent and active tuberculosis : state of the art and future prospects. Semin Respir Crit Care Med 2008; 29: 560-568.
23. Parron M, Torres I, Pardo M et al. The halo sign in computed tomography images: differentiation and correlation with pathology findings. Arch Bronconeumol 2008; 44: 386-392.
24. Reuter S, Grüner B, Buck AK et al. Long-term follow-up of metabolic activity in human alveolar echinococcosis using FDG-PET. Nuklearmedizin 2008; 47: 147-152.
25. Strobel K, Stumpe K. PET/CT in musculoskeletal infection. Semin Musculoskelet Radiol 2007; 11: 353-364.
26. Valdés L, Pose A, San José E, Martinez Vazquez J. Tuberculous pleural effusions. Eur J Intern Med 2003; 14: 77-88.
27. 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 2001; 42: 1412-1417.